Diabete Type 2 Clinical Trials

17 recruiting

Frequently Asked Questions

Common questions about Diabete Type 2 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting

Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

Diabete Type 2Alzheimer Dementia (AD)
Rigshospitalet, Denmark60 enrolled1 locationNCT07482072
Recruiting

The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness and Cardiac Deformation After Acute Myocardial Infarction

Diabete Type 2Myocardial Infarction (MI)
University of Athens80 enrolled1 locationNCT07469943
Recruiting

Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.

Diabete Type 2PARKINSON DISEASE (Disorder)Alzheimer s Disease
Neuromed IRCCS500 enrolled1 locationNCT07467460
Recruiting
Phase 3

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Cardiovascular DiseasesDiabete Type 2
Montreal Heart Institute10,000 enrolled39 locationsNCT05633810
Recruiting
Not Applicable

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Obesity, OverweightDiabete Type 2Insulin Resistance Syndrome
Clinica Universidad de Navarra, Universidad de Navarra150 enrolled1 locationNCT07415720
Recruiting
Phase 3

Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes

Diabete Type 2
Unity Health Toronto390 enrolled1 locationNCT05776420
Recruiting

Risk Factors for Developing Peak Plantar Pressure During Walking in the Diabetic Patients

Diabete Type 2
China Medical University Hospital120 enrolled1 locationNCT07164495
Recruiting
Not Applicable

Pocket-X Gel Non-surgical Periodontal Therapy

Diabete Type 2
Universita di Verona70 enrolled1 locationNCT07372677
Recruiting

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Depression - Major Depressive DisorderAnorexia NervosaBulimia Nervosa+17 more
Forschungsinstitut der Diabetes Akademie Mergentheim1,809 enrolled3 locationsNCT07212075
Recruiting
Phase 3

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

Diabete Type 2T2DMDM
Celltrion171 enrolled1 locationNCT07093476
Recruiting
Not Applicable

Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion

Diabete Type 2Abdominal Obesity
Centre Hospitalier Universitaire Dijon45 enrolled1 locationNCT04940962
Recruiting
Phase 2

Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees

AmputationDiabete Type 2
Spaulding Rehabilitation Hospital38 enrolled1 locationNCT05656924
Recruiting
Phase 1Phase 2

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Diabete Type 2
Biolingus15 enrolled1 locationNCT05268237
Recruiting
Not Applicable

EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients

Cardiovascular DiseasesOverweight and ObesityDiabete Type 2
Fondazione Don Carlo Gnocchi Onlus105 enrolled1 locationNCT05987410
Recruiting

SGLT-2 Inhibitors in the Treatment of Ascites

Cirrhosis, LiverDiabete Type 2Ascites Hepatic
University of Palermo40 enrolled2 locationsNCT05999773
Recruiting

Time Spent In Target Glucose Range in Women With T2D Diabetes in Pregnancy

Diabete Type 2Pregnancy in Diabetic
Mount Sinai Hospital, Canada50 enrolled1 locationNCT06147466
Recruiting
Not Applicable

Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes

Diabete Type 2
Ramsay Générale de Santé230 enrolled1 locationNCT05325710